Tocainide: Interstitial pneumonitis

Tocainide-associated interstitial pneumonitis.

Desquamative interstitial pneumonitis vs usual interstitial pneumonitis.

My colleague and collaborator, the late Edgar G. Harrison, Jr., M.D., was of the opinion that “desquamation” was a fundamental phenomenon in the spectrum of usual interstitial pneumonitis. In our report’ on classic interstitial pneumonitis-flbrosis, we found that almost two-thirds of our biopsies revealed this finding. Harrison believed that the designation, “desquamative interstitial pneurnoni...

Desquamative Interstitial Pneumonitis vs Usual Interstitial Pneumonitis

My colleague and collaborator, the late Edgar G. Harrison, Jr., M.D., was of the opinion that “desquamation” was a fundamental phenomenon in the spectrum of usual interstitial pneumonitis. In our report’ on classic interstitial pneumonitis-flbrosis, we found that almost two-thirds of our biopsies revealed this finding. Harrison believed that the designation, “desquamative interstitial pneurnoni...

Amiodarone-induced interstitial pneumonitis.

To cite: Voruganti DC, Cadaret L. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2017219373 DESCRIPTION A man aged 62 years presented with shortness of breath (SOB) for 1 week. He has a history of nonischaemic cardiomyopathy, diabetes mellitus and atrial fibrillation (AF). ECG revealed AF with rapid ventricular rate and chest X-ray was consistent with pulmonary c...

Docetaxel-related interstitial pneumonitis

Docetaxel (Taxotere(®)) is an agent that is indicated for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer. In recent years, docetaxel-related interstitial lung disease (ILD) has been reported in several case series studies. The onset of ILD occurred ~10-20 days (median time: 18 days) after docetaxel administration. Here, we reported the case of a patient...